X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (852) 852
Publication (58) 58
Book Chapter (13) 13
Web Resource (3) 3
Book / eBook (1) 1
Book Review (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (524) 524
science & technology (480) 480
life sciences & biomedicine (479) 479
cardiovascular system & cardiology (415) 415
peripheral vascular disease (331) 331
male (306) 306
hypertension (278) 278
middle aged (230) 230
hypertension - drug therapy (228) 228
female (224) 224
blood pressure (196) 196
aged (186) 186
antihypertensive agents - therapeutic use (183) 183
risk factors (166) 166
hypertension - physiopathology (141) 141
hypertension - complications (118) 118
adult (114) 114
blood pressure - drug effects (96) 96
cardiac & cardiovascular systems (94) 94
treatment outcome (90) 90
medical and health sciences (83) 83
medicin och hälsovetenskap (83) 83
electrocardiography (77) 77
double-blind method (71) 71
losartan - therapeutic use (71) 71
drug therapy (67) 67
atenolol - therapeutic use (66) 66
aged, 80 and over (58) 58
abridged index medicus (56) 56
follow-up studies (54) 54
randomized controlled trials as topic (54) 54
hypertrophy (51) 51
hypertension - diagnosis (50) 50
heart rate (49) 49
blood pressure - physiology (48) 48
cardiovascular diseases - prevention & control (47) 47
prospective studies (47) 47
drug therapy, combination (43) 43
hypertension - therapy (42) 42
prognosis (42) 42
mortality (41) 41
cardiovascular disease (40) 40
hypertension - blood (40) 40
norepinephrine - blood (40) 40
cardiovascular diseases (39) 39
epinephrine - blood (39) 39
hypertrophy, left ventricular - complications (39) 39
antihypertensive agents - administration & dosage (38) 38
cardiovascular diseases - etiology (38) 38
proportional hazards models (38) 38
cardiac and cardiovascular systems (35) 35
cardiology and cardiovascular medicine (35) 35
kardiologi (35) 35
stroke (34) 34
angiotensin ii type 1 receptor blockers - therapeutic use (33) 33
losartan/therapeutic use (33) 33
risk assessment (33) 33
atenolol/therapeutic use (32) 32
cardiology (32) 32
cardiovascular (32) 32
cardiovascular diseases - mortality (32) 32
clinical medicine (32) 32
clinical trials as topic (32) 32
hypertension - epidemiology (32) 32
incidence (32) 32
klinisk medicin (32) 32
heart failure (31) 31
hypertrophy, left ventricular - drug therapy (30) 30
predictive value of tests (30) 30
hypertrophy, left ventricular - physiopathology (29) 29
antihypertensive agents/therapeutic use (28) 28
atenolol (28) 28
care and treatment (28) 28
losartan (28) 28
atrial fibrillation (27) 27
catecholamines (27) 27
europe (27) 27
general & internal medicine (27) 27
medicine, general & internal (27) 27
time factors (26) 26
hypertension - mortality (25) 25
antihypertensive agents (24) 24
hypertension - surgery (24) 24
left ventricular hypertrophy (24) 24
adrenergic beta-antagonists - therapeutic use (23) 23
antihypertensive agents - adverse effects (23) 23
diabetes (23) 23
heart rate - drug effects (23) 23
internal medicine (23) 23
practice guidelines as topic (23) 23
regression analysis (23) 23
stroke - prevention & control (23) 23
angiotensin-converting enzyme inhibitors - therapeutic use (22) 22
cardiovascular risk (22) 22
diabetes mellitus (22) 22
electrocardiogram (22) 22
kidney - innervation (22) 22
risk (22) 22
tetrazoles - therapeutic use (22) 22
valsartan (22) 22
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (867) 867
Norwegian (54) 54
Danish (6) 6
Polish (4) 4
Italian (3) 3
Spanish (3) 3
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiovascular Drugs, ISSN 1175-3277, 2003, Volume 3, Issue 5, pp. 378 - 379
... hypertrophy (LVH) and improvements in cardiac func- Losartan tion, which may be partly explained by the effect of losartan in A Viewpoint by Sverre E. Kjeldsen... 
Hypertension | Stroke, general | Angiotensin II 1 receptor antagonists, general | Losartan, general | Adis Drug Profiles | Left ventricular hypertrophy | Pharmacotherapy | Medicine & Public Health | Cardiology | Pharmacology/Toxicology | Control | Losartan | Angiotensin | Dosage and administration | Research | Drug therapy | Health aspects
Journal Article
Pharmacological research, ISSN 1043-6618, 03/2018, Volume 129, pp. 95 - 99
[Display omitted] Hypertension is the strongest or one of the strongest risk factors for almost all different cardiovascular diseases acquired during life,... 
Hypertension | Target organ damage | Renal disease | Blood pressure | Cardiovascular risk | Cerebral stroke | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Blood Pressure | Cardiovascular Diseases - epidemiology | Humans | Risk Factors | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 56, Issue 1, pp. 77 - 85
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2018, Volume 39, Issue 28, pp. 2616 - 2617
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2013, Volume 61, Issue 2, pp. 268 - 269
Journal Article
The American journal of cardiology, ISSN 0002-9149, 03/2012, Volume 109, Issue 5, pp. 685 - 692
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2002, Volume 359, Issue 9311, pp. 995 - 1003
Journal Article